A-kinase-anchoring protein 149 (AKAP149) is a membrane protein of the mitochondrial and endoplasmic reticulum/nuclear envelope network. AKAP149 controls the subcellular localization and temporal order of protein phosphorylation by tethering protein kinases and phosphatases to these compartments. AKAP149 also includes an RNA-binding K homology (KH) domain, the loss of function of which has been associated in other proteins with neurodegenerative syndromes. We show here that protein phosphatase 1 (PP1) binding occurs through a conserved RVXF motif found in the KH domain of AKAP149 and that PP1 and RNA binding to this same site is mutually exclusive and controlled through a novel, phosphorylation-dependent mechanism.
INTRODUCTION
Subcellular localization and temporal organization of protein phosphorylation by protein kinase A (PKA) are mediated by proteins collectively termed A-kinase-anchoring proteins (AKAPs) (1) . AKAPs bind a PKA regulatory subunit dimer, and a targeting domain specifies subcellular localization. AKAPs also interact with other signalling molecules such as protein kinase C (PKC), phosphodiesterases and protein phosphatases (PPs) including PP1 in a space-and time-regulated fashion (1, 2) .
AKAP149 (also termed D-AKAP1; AKAP121 in mouse) is a human 149 kDa anchoring protein localized in mitochondria and the endoplasmic reticulum/nuclear envelope (ER -NE) network (3, 4) . In addition to PKA, AKAP149 co-precipitates PKCa from NE fractions (5) and binds phosphodiesterase PDE4A (6) . AKAP121 also binds PTPD1, an Src-associated classical non-receptor protein tyrosine phosphatase, and Src itself (7) . These findings suggest that AKAP149 is an important scaffolding molecule for phosphorylation events in the mitochondrial/ER -NE compartments.
PP1, a member of the PPP family of Ser/Thr phosphatases, has been implicated in a range of cellular processes including muscle contraction, cell division and pre-mRNA splicing by dephosphorylation of key proteins such as RNA polymerase II, SR-splicing factors and retinoblastoma protein (8 -12) .
PP1 usually consists of a catalytic and a regulatory subunit (8, 13) . The latter serves to target the catalytic subunit to the proximity of its substrate. Most PP1 regulators contain an RVXF motif that interacts with the hydrophobic pocket of PP1. AKAP149 harbours two canonical RVXF motifs: the previously characterized 153 
KGVLF
157 (3) and the uncharacterized 627 RYVSF 631 located in the RNA-binding K homology (KH) domain. We earlier demonstrated that AKAP149 functions as a PP1 regulatory subunit and enhances PP1 phosphatase activity towards B-type lamins upon NE re-formation at the end of mitosis, thus promoting lamin dephosphorylation and polymerization to assemble the nuclear lamina (3, 14) .
AKAP121, the mouse orthologue of AKAP149, binds the 3 0 untranslated region (UTR) of two mitochondrial protein transcripts (MnSOD and F 0 F) in vitro (15) and of lipoprotein lipase mRNA (16) . In both cases, binding of AKAP121 to mRNA is mediated by a single COOH-terminal KH domain. KH domains bind RNA or ssDNA and are found in proteins associated with pre-mRNA splicing, as well as mRNA stabilization, subcellular localization and translational regulation. Interestingly, several diseases such as fragile X mental retardation syndrome and paraneoplastic opsoclonus-myoclonus-ataxia (POMA) neurodegenerative syndrome are associated with the loss of function of a KH domain in specific proteins (17, 18 (Fig. 1A) . Surprisingly, neither PP1a-EGFP nor PP1g-EGFP co-precipitated with HA-AKAP149 (1-485) (Fig. 1C) , with or without an RAXA double mutation known to abolish or reduce PP1 binding (20, 21) . However, both PP1 isoforms co-precipitated with HA-AKAP149 (KHT) (Fig. 1D) , and this co-precipitation was reduced when the RAXA substitutions were introduced into 627 RYVSF 631 (Fig. 1D) . Therefore, AKAP149 interacts with both tagged PP1a and PP1g preferentially through the COOHterminal 627 
RYVSF
631 motif in co-immunoprecipitation assays. The absence of a strong detectable interaction with PP1 mediated by the NH 2 -terminal RVXF motif of AKAP149 was confirmed by anti-GFP immunoprecipitation of EGFPtagged full-length AKAP149 constructs harbouring phosphorylation-deficient or constitutively phosphorylated mutations of the serines flanking motif of AKAP149 directly interacts with PP1 was determined in a GST pulldown experiment using GST-tagged AKAP149 (KHT) and purified PP1a in solution. As shown in Figure 1E (left two lanes), PP1a bound to AKAP149 (KHT) but not to the AKAP149 (KHT, RAXA) mutant, demonstrating a direct interaction of AKAP149 with PP1a through the 627 (Fig. 2A) . The S630D pseudo-phosphorylation mutation in 627 RYVSF 631 resulted in weakened association between HA-AKAP149 (KHT) and PP1g-EGFP, whereas the S630A phosphorylationdeficient mutant showed reinforced interaction ( Fig. 2A) . Similar results were obtained when full-length S630A and S630D AKAP149 constructs were used (Supplementary Material, Fig. S2C ). The negative effect of phosphorylation of 627 RYVSF 631 on interaction with PP1 was also demonstrated by the absence of interaction of GST-AKAP149 (KHT, S630D) with purified recombinant PP1a in a GST pulldown assay ( Table S1 ). Therefore, binding of the 627 RYVSF 631 motif decreases upon S630 phosphorylation within the RVXF (and KH) motif.
AKAP149 binds directly to RNA in a Ser phosphorylation-dependent manner
To confirm previous assessments that the KH domain of AKAP149 associates with RNA (15, 19) and extend the observations to an in vivo context, we performed an RNA immunoprecipitation experiment following UV cross-linking (19) . 293T cells were UV cross-linked, RNA partially digested with RNase T 1 and immunoprecipitation was carried out using anti-AKAP149 antibodies. Immunoprecipitated RNA was g- conditions (Fig. 3A) , thus AKAP149 directly associates with RNA in living cells.
To characterize the RNA binding properties of AKAP149, we expressed EGFP-tagged wild-type or various mutant KH-Tudor domain constructs in 293T cells (Fig. 3B) . AKAP149-RNA complexes were immunoprecipitated using anti-GFP antibodies and immune complexes subjected to autoradiography. Western blotting with anti-GFP antibodies (aGFP) revealed comparable amounts of EGFP-tagged proteins immunoprecipitated in all conditions (Fig. 3B) . Autoradiography showed RNA/protein complexes precipitated by wild-type AKAP149 (KHT)-EGFP and with the pseudo-phosphorylated AKAP149 (KHT, S630D)-EGFP fragment. However, very little if any RNA was co-precipitated with the AKAP149 (KHT, S630A)-EGFP phosphorylation-deficient protein nor with AKAP149 (KHT, V629E)-EGFP, which was substituted in the hydrophobic groove of the KH domain (19) (Fig. 3B) . As expected, the PP1-binding deficient AKAP149 (KHT, RAXA)-EGFP mutant did not show any RNA association. Collectively, these results suggest that the KH domain of AKAP149 associates with RNA when S630 is phosphorylated, whereas dephosphorylation of the same residue prevents RNA binding.
To confirm this finding, extracts from 293T cells transiently expressing EGFP-tagged AKAP149 (KHT), (KHT, V629E), (KHT, RAXA), (KHT, S630D) and (KHT, S630A) were treated with T 1 RNase to partially digest RNA, the protein fragments immunoprecipitated using anti-GFP antibodies and immune complexes were g-32 P end-labelled before RNA elution and visualization by autoradiography. Wild-type KH-Tudor shows association with a population of RNA molecules (Fig. 3C, lane 1) . This association was maintained with the S630D substitution in the KHT fragment (lane 7), arguing that in contrast to PP1 binding, S630 phosphorylation does not affect RNA binding. However, RNA co-precipitation was strongly reduced with S630A substitution (lane 9), suggesting a role of S630 phosphorylation in maintaining KHT interaction with RNA. Similar results were obtained when fulllength S630A and S630D AKAP149 constructs were used (Supplementary Material, Fig. S2A and B) . Furthermore, V629E or RAXA substitution of AKAP149 protein fragments also strongly reduced association with RNA (lanes 4 and 6), indicating that an intact hydrophobic groove within the KH domain is necessary to maintain interaction with RNA.
The V629E mutation weakens interaction between AKAP149 and PP1
The previous experiments show that the KH domain associates with RNA or PP1 through an inverse, phosphorylation-dependent process. We next addressed whether the RNA binding-deficient V629E mutation in 627 RYVSF 631 showed a similar binding exclusivity for PP1 or RNA. We first verified that PP1 binding to the KH domain was unaltered after RNase treatment in coimmunoprecipitation studies from lysates of PP1g-EGFPexpressing HeLa cells transfected with HA-AKAP149 (KHT) (Fig. 3D) , indicating that RNA is not required for PP1 binding. We next immunoprecipitated EGFP-tagged PP1a, PP1d or PP1g from HeLa cells co-expressing HA-AKAP149 (KHT) or AKAP149 (KHT, V629E). The V629E mutant showed reduced association between KHT and all three PP1 isoforms (Fig. 3E) . Thus, the V629E mutation strongly diminishes the binding of both PP1 and RNA, unlike the S630A or D mutations. We concluded that binding of PP1 and RNA to the KH domain is mutually exclusive and regulated by an inverse phosphorylation mechanism on S630. 
RNA-binding deficient AKAP149 causes a collapse of the mitochondrial network
To gain insights into the functional significance of the KH domain of AKAP149, we examined the effect of disrupted binding to PP1 and RNA in HeLa cells. Full-length AKAP149-EGFP, AKAP149 (V629E)-EGFP, AKAP149 (1-485)-EGFP, AKAP149 (S630A)-mCherry and -(S630D) -mCherry were transiently expressed in HeLa cells. The AKAP149 sequence used for all constructs was the orthologue of the mouse AKAP121-(N0) splice variant, which targets the mitochondrial membrane (23) . Accordingly, AKAP149-EGFP localizes to mitochondria in cells showing an apparently normal mitochondrial network (Fig. 4A) . A similar phenotype was observed for AKAP149 (S630D) with intact RNA binding and reduced PP1-binding ( Fig. 4B and C) . Strikingly, however, the expression of both RNA binding-deficient AKAP149 (V629E) and AKAP149 (S630A) resulted in pronounced aggregation of mitochondria in 30-50% of the cells (Fig. 4A-C) . A similar effect was observed with AKAP149 (1-485), lacking the KH-Tudor domain (Fig. 4A-C) . The aggregates did consist of mitochondria, as judged by co-labelling of DMDDX28-EGFP, a construct targeting to the inner mitochondrial membrane (24) , with wild-type or mutant AKAP149-mCherry (Fig. 4C) . Note that all AKAP149-mCherry constructs targeted mitochondria with a more peripheral location than DMDDX28-EGFP, probably corresponding to the outer mitochondrial membrane (Fig. 4C) . The aggregation of the mitochondrial network could result from an alteration of the microtubules network, involved in mitochondrial positioning (25) and which has been reported to interact with AKAP149 (26). However, a-tubulin immunolabelling showed that the microtubule network was apparently normal in cells expressing AKAP149 (1-485)-EGFP with aggregated mitochondria (Supplementary Material, Fig. S3 ). Collectively, these results indicate that the expression of mitochondria-targeted, RNA binding-deficient AKAP149 mutants results in a collapse of the mitochondrial network.
DISCUSSION
We demonstrate that AKAP149 contains a functional COOHterminal 627 
RYVSF
631 motif within the conserved KH domain, in addition to the previously characterized 153 KGVLF 157 motif situated in the NH 2 terminus (3). The existence of two PP1-binding RVXF motifs is not exclusive for AKAP149 and has been reported for two other regulatory subunits of PP1, Sipp1 and Aurora A kinase (20, 27 A feature of AKAP149 is the presence of a conserved PP1-binding RVXF motif within the KH RNA-binding domain. This is also the case for the RNA splicing protein tra2-beta1, which shares the presence of an evolutionary conserved PP1-docking motif in the RNA recognition motif with eight other proteins, including SF2/ASF, SRp30c and polypyrimidine tract-binding protein (11) . The emerging number of RNA-binding proteins with PP1-binding motifs in their RNAbinding domain suggests a complex phosphorylationdependent regulation of RNA transport, processing and splicing. An additional level of complexity is provided for AKAP149 by the fact that it also anchors kinases such as PKA and PKC (3, 5) Ãpep at steady state (Fig. 2C ). This could correspond to dephosphorylation by PP1, followed by binding of the newly dephosphorylated peptide. Similarly, we show that RNA binding to the KH domain is also affected by the phosphorylation status of the 627 RYVSF 631 motif, but in the opposite way, in that S630 phosphorylation allows RNA binding. It has already been shown that binding of the 3 0 -UTR of several mRNAs to AKAP149/AKAP121 is stimulated by PKA phosphorylation (15, 16) . However, a regulation by phosphorylation of the binding of RNA and PP1 has, to our knowledge, not been previously reported for the same site of a single protein domain. This mutually exclusive phosphorylationregulated binding of either RNA or PP1 represents a novel and original switching mechanism to control binding of a PP and RNA molecule to the same domain of a signalling complex protein.
Substitutions disrupting the RNA-binding features of the KH domain of AKAP149/AKAP121 lead to a mitochondrial aggregation phenotype. This is similar to the aberrant accumulation of mitochondria observed with a GTP-binding deficient mutant of the mitochondrial AKAP Rab32, a member of the Ras superfamily of small G-proteins (28) . The authors propose a role for Rab32 in the regulation of mitochondrial fission. We have noted for the RNA-binding-deficient mutants of AKAP149 that the collapsed mitochondria appear rounded rather than an elongated rod-like shape, suggesting fragmentation of the mitochondrial network. However, the mechanism of this mitochondrial collapse is likely to be different as Rab32 has no characterized RNA-binding domain. AKAP121 has been proposed to target important mitochondrial mRNAs such as Mn-superoxide dismutase or the ATP synthase subunit Fo-f to mitochondria through the KH domain (15) . Thus, speculatively, AKAP149 may be involved in the regulation of mitochondrial fusion/fission mechanisms (29) , possibly by localizing one or more of the required mRNAs to the mitochondrial membrane.
More generally, correct targeting of mRNAs to the mitochondrial membrane by AKAP149 could play an important role in the regulation of post-transcriptional gene expression. It is becoming increasingly clear that mRNA localization is involved in the sorting of several proteins destined to organelles, especially in mitochondrial biogenesis, which is a complex process requiring the concerted expression of both nuclear and mitochondrial genomes (30) . In Saccharomyces cerevisiae, half of the transcripts coding for mitochondrial proteins preferentially localize to the organelle surface (31) , and this is also observed in human cells (30) .
mRNA mistargeting to the mitochondrial membrane may also result in mitochondrial dysfunction, which is often involved in neurodegenerative diseases (32) . It has been proposed that mRNA sorting, by providing a mechanism for non-uniform protein distribution, is critical in the spatial architecture of polarized cells such as neurons (31) . An important aspect of gene expression in neurons involves the delivery of mRNAs to particular subcellular domains, where translation of the mRNAs is locally controlled. This local synthesis of protein within dendrites plays a key role in activity-dependent synaptic modifications such as long-term potentiation and long-term depression. In growing axons, local synthesis in the growth cone is important for extension and guidance (33) . Perturbations in mRNA transport and local translation could thus result in several human neurodegenerative diseases. As a matter of fact, spinal muscular atrophy is caused by mutation of the SMN1 gene that results in a truncated and unstable version of the SMN protein, which normally promotes an assembly of specific RNA-binding proteins with their target sequences (34) . Even more interestingly, fragile X mental retardation syndrome and POMA are neurodegenerative diseases linked to impaired RNA binding, resulting from the loss of function of a specific KH domain (17) . It is therefore tempting to speculate that mRNA sorting perturbation arising from impaired RNA anchoring at the KH domain of mitochondrial AKAP149 might be in a similar fashion at the origin of some neurodegenerative disorders.
We report for the first time a phosphorylation-dependent mechanism to regulate binding of RNA and PP1 in a mutually exclusive manner to the single KH domain on the AKAP149 signalling complex. We also show implications for mitochondrial distribution of a defective RNA binding to the same mitochondria-targeted AKAP149 signalling scaffold. Further efforts need to focus on identifying the specific RNA molecule(s) binding to AKAP149 and the nature and functional significance of the phosphorylation/dephosphorylation pathways regulating it.
MATERIALS AND METHODS

Cloning and expression of AKAP149 proteins
Fragments of AKAP149 cDNA (full-length; nucleotides 1-2712; KH-Tudor; nucleotides 1736-2712; 1-485; nucleotides 1 -1436) were amplified by PCR, using primers that appended a 5
0 EcoRI site and a 3 0 BamHI site (EGFP constructs), a 5
0 EcoRI site and a 3 0 NotI site (GST constructs), a 5
0 EcoRI site and a 3 0 NotI site (HA constructs) or a 5 0 HindIII and a 3 0 SacII site (mCherry constructs). Amplified cDNA was digested with appropriate restriction enzymes and cloned into pEGFP-N3 or pmCherry-N1 (Clontech), pGEX-4T-1 (Pharmacia) or pET-BOS-HA (19) . For mutagenesis, we used the Quick change Site-Directed Mutagenesis Kit (Stratagene).
Antibodies
Monoclonal anti-AKAP149 antibodies (mAbs) (Transductions Laboratories) were against residues 66-212 of human AKAP149. Rabbit polyclonal anti-GFP was from BD Biosciences and monoclonal anti-GFP antibodies were from Roche. Anti-HA mAbs were from Nordic Biosite. Anti-a-tubulin and anti-g-tubulin were from Sigma. Polyclonal anti-PP1 was from Santa Cruz. Cy2-, Cy3-and peroxidase-conjugated secondary antibodies were from Jackson Laboratories.
Cell culture and transfection
HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM)/1% glutamine/1% Na-pyruvate/1% nonessential amino acids/10% fetal calf serum. 293T cells were cultured in RPMI1640 supplemented as above. Cells were transfected using Effectene Transfection (Qiagen). Briefly, for immunofluorescence, cells were plated in DMEM on cover slips at 0.8Â10 5 cells/well of a 12-well plate. After 24 h, 200 ml EC Buffer (Qiagen) containing 4 -10 ml enhancer, 5 -15 ml Effectene and 0.5-1.5 mg DNA was added. Cells were incubated for 24 h and processed for microscopy. For immunoprecipitation, cells were seeded in 75 cm 2 culture flasks to 40-70% confluence 24 h before transfection.
Immunological procedures
Western blotting was performed as described earlier (35) using anti-AKAP149 (1:1000), anti-GFP (1:1000) or anti-HA (1:1000) antibodies. For immunoprecipitation, HeLa cells were harvested, washed, suspended in immunoprecipitation buffer (10 mM HEPES, pH 7.5, 10 mM KCl, 2 mM EDTA, 1% Triton X-100) adjusted to 100 -250 mM KCl and allowed to swell for 15 min before sonication (1 min and 20 s). The lysate was centrifuged at 15 000g for 5 min. RNAse A-treated lysates were prepared, as described (19) . After pre-clearing, immunoprecipitation was carried out with relevant antibodies (1:50; 48C for 2 h) and incubation with Magnetic Protein G-Sepharose beads (Dynal) at 48C for 1 h. Immune precipitates were washed three times with immunoprecipitation buffer adjusted to 100 -250 mM KCl, and proteins were eluted in SDS sample buffer. Immunofluorescence was performed after paraformaldehyde fixation and permeabilization with 0.1% Triton X-100 or 1 minute methanol fixation, as described earlier (35) . Cells were probed with anti-a-tubulin (1:1000) or anti-g-tubulin (1:1000), followed by secondary antibodies conjugated with Cy3 (1:300). DNA was labelled with 0.25 mg/ml DAPI (Sigma). Samples were examined on an Olympus BX51 microscope using AnalySIS (Soft Imaging Systems). 
Synthesis of peptides for SPR
SPR analysis
SPR analysis was performed with a Biacore T100 instrument and analysed with the Biacore T100 evaluation software (Biacore AB). Recombinant PP1a (Sigma) (5 mg) diluted in the coupling buffer [10 mM acetate, pH 5.5, 1 mM DTT, 2 mM MnCl 2 and 5 mM okadaic acid (sodium salt; Sigma] was immobilized covalently on a hydrophilic carboxymethylated dextran matrix [Sensor chip CM5 (Biacore AB)] with the amine coupling procedure essentially as described before (36) with 10 ml/min flow for 600 s. The remaining free succinimide ester groups were blocked with 1 M ethanolamine. During coupling and binding experiments, the assay buffer [25 mM Tris -HCl, pH 7.4, 150 mM NaCl, 1 mM DTT, 2 mM MnCl 2 , 0.05% P20 (Biacore AB), 5% DMSO] was used. For binding studies, +1600 RU recombinant PP1a was immobilized. The reference channel was treated similarly, but without recombinant PP1a. After coupling, assay buffer containing 0.05% SDS was passed through both surfaces (5 ml/min) overnight to minimize non-specific binding of the analytes to the biosensor surface. The following day plain assay buffer was passed through both channels 5 h before experimental start to remove SDS from the chip area and stabilize the baseline. All biosensor analyses were performed at 258C with the assay buffer at a standard constant flow of 10 ml/min. The binding of KHT, KHT RAXA, KHT S630
Ã , 1-485 and 1 -485 RAXA peptides (analytes) on the immobilized enzyme was studied by injecting (10 ml/min) different concentrations of the analytes for 300 s. All sensograms were processed by first subtracting the SPR response observed for the reference surface to correct for any contribution of non-specific interaction with the dextran matrix.
RNA immunoprecipitation
Procedure was described previously (19) . Briefly, transiently transfected 293T cells were UV-crosslinked (200 mJ/cm 2 , 254 mn, twice). Cells were harvested, washed and suspended in IPB containing 150 mM KCl. Cells were RNase T 1 (0.002 U) digested for 8 min before sonication (10Â30 s). The lysate was centrifuged at 15 000g for 15 min. After preclearing, immunoprecipitation was performed with Magnetic Protein G -Sepharose beads coated with relevant antibody (1:50) at 48C for 2 h. Immune precipitates were washed four times in alternating fashion with RIPA (1Â PBS, 0.05% SDS, 0.1% deoxycholate, 1% NP-40) and RIPA containing 1 M NaClþ1 mM EDTA. Precipitates were dephosphorylated with calf intestinal phosphatase (Roche) for 10 min at 378C and washed twice with buffer D (50 mM Tris -HCl, pH 7.4, 20 mM EGTA) and twice with buffer C (50 mM Tris-HCl, pH 7.4, 10 mM MgCl 2 , 0.5% NP-40). Precipitates were incubated overnight at 168C in a Thermomixer with a 30 s shake at 1000 rpm every 3 min. Precipitates were end-labelled with [g- 32 P]ATP and either (i) resolved in a 7.5% urea-gel and visualization by autoradiography, (ii) dissolved in SDS sample buffer separated in a 10% Tris-HCl protein gel and visualized by autoradiography, or (iii) eluted in SDS sample buffer and visualized by SDS -PAGE.
